Martin Louis Wilson - 14 Feb 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
General Counsel
Signature
/s/ Martin Louis Wilson
Issuer symbol
RCKT
Transactions as of
14 Feb 2023
Net transactions value
$0
Form type
4
Filing time
16 Feb 2023, 15:45:43 UTC
Previous filing
16 Aug 2022
Next filing
16 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +87,147 $0.000000 87,147 14 Feb 2023 Common Stock 87,147 $20.04 Direct F1
transaction RCKT Restricted Stock Units Award $0 +29,079 $0.000000 29,079 14 Feb 2023 Common Stock 29,079 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 87,147 shares of the Issuer's common stock, one-third (1/3) of which will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F3 One-third (1/3) of such restricted stock units will become fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.